Hepatitis B screening bij zwangeren: een overzicht van 1991

Show simplified metadata
dc.contributor.authorLoeber JG
dc.contributor.authorGrosheide PM
dc.date.accessioned2012-12-12T13:35:52Z
dc.date.available2012-12-12T13:35:52Z
dc.date.issued1992-10-31
dc.date.updated2012-12-12T13:35:52Z
dc.description.abstractIn October 1989 routine screening for hepatitis B surface antigen (HBsAg) in all regnant women was introduced in the Netherlands. In order to prevent hepatitis B infection in their offspring all infants of HBsAg-positive mothers receive passive active immunization. During 1991 about 75% of the estimated total number of pregnant women was screened for HBsAg in the regional laboratories appointed by the National Institute of Public Health and Environmental Protection. It is currently unknown whether the remaining 25% of the pregnant women were screened and if so, where. The organisation of the screening will be investigated in detail in the 4th trimester of 1992. The overall prevalence of HBsAg-positivity was 0.47% in 1991, with a range of 0.2% in rural areas to 0.9% in the city of Amsterdam. The overall percentage of HBsAg-positive women is similar to the prevalence found in 1990, but much lower than the originally expected percentage of 0.8%. The question therefore is whether the women not reached by the programme belong to the high risk groups for hepatitis B. A number of regional laboratories did not provide details concerning their analytical performance. In some laboratories the current procedures should be reconsidered.<br>
dc.description.sponsorshipGHI
dc.format.extent67 p
dc.identifier199003015
dc.identifier.urihttp://hdl.handle.net/10029/256141
dc.language.isonl
dc.publisherRijksinstituut voor Volksgezondheid en Milieu RIVM
dc.relation.ispartofRIVM Rapport 199003015
dc.relation.urlhttp://www.rivm.nl/bibliotheek/rapporten/199003015.html
dc.subject05nl
dc.subjecthepatitis bnl
dc.subjectscreeningnl
dc.subjectzwangerschapnl
dc.subjectbemonsteringnl
dc.subjectbepalingnl
dc.subject92-4nl
dc.subjecthepatitis ben
dc.subjectscreeningen
dc.subjectpregnancyen
dc.subjectsamplingen
dc.subjectassayen
dc.titleHepatitis B screening bij zwangeren: een overzicht van 1991nl
dc.title.alternativeHepatitis B screening in pregnancy: results over 1991en
dc.typeReport
dspace.entity.typePublication
html.description.abstractIn October 1989 routine screening for hepatitis B surface antigen (HBsAg) in all regnant women was introduced in the Netherlands. In order to prevent hepatitis B infection in their offspring all infants of HBsAg-positive mothers receive passive active immunization. During 1991 about 75% of the estimated total number of pregnant women was screened for HBsAg in the regional laboratories appointed by the National Institute of Public Health and Environmental Protection. It is currently unknown whether the remaining 25% of the pregnant women were screened and if so, where. The organisation of the screening will be investigated in detail in the 4th trimester of 1992. The overall prevalence of HBsAg-positivity was 0.47% in 1991, with a range of 0.2% in rural areas to 0.9% in the city of Amsterdam. The overall percentage of HBsAg-positive women is similar to the prevalence found in 1990, but much lower than the originally expected percentage of 0.8%. The question therefore is whether the women not reached by the programme belong to the high risk groups for hepatitis B. A number of regional laboratories did not provide details concerning their analytical performance. In some laboratories the current procedures should be reconsidered.&lt;br&gt;
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.65 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
RIVM official reports